Summit X LLC’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,855
Closed -$1.78M 227
2023
Q2
$1.78M Buy
5,855
+69
+1% +$19.2K 0.43% 43
2023
Q1
$1.53M Sell
5,786
-55
-0.9% -$14K 0.39% 49
2022
Q4
$982K Sell
5,841
-15
-0.3% -$3.36K 0.28% 80
2022
Q3
$1.07M Buy
5,856
+15
+0.3% +$2.99K 0.32% 71
2022
Q2
$984K Sell
5,841
-5
-0.1% -$1.07K 0.28% 79
2022
Q1
$1.47M Sell
5,846
-50
-0.8% -$12.6K 0.36% 62
2021
Q4
$1.51M Sell
5,896
-45
-0.8% -$11K 0.35% 64
2021
Q3
$1.44M Hold
5,941
0.36% 60
2021
Q2
$1.23M Sell
5,941
-80
-1% -$16.3K 0.31% 75
2021
Q1
$1.13M Sell
6,021
-105
-2% -$18.5K 0.31% 79
2020
Q4
$1.01M Sell
6,126
-99
-2% -$14.5K 0.3% 81
2020
Q3
$5.49K Buy
6,225
+2,290
+58% +$283K 0.09% 111
2020
Q2
$382K Buy
+3,935
New +$409K 0.14% 145

Other funds holding HCA

Summit X LLC's HCA Position: Q3 2023 in Review

Summit X LLC sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 5,855 shares — an estimated $1.78M sold.

Summit X LLC first reported a position in HCA in Q2 2020 and held it in 13 quarters. The position peaked at $1.78M in Q2 2023. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Summit X LLC reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
  • Summit X LLC sold 5,855 HCA Healthcare shares in Q3 2023, an estimated $1.78M.
  • Summit X LLC first reported a position in HCA Healthcare in Q2 2020 and held it in 13 quarters.
  • Summit X LLC's HCA Healthcare position peaked at $1.78M in Q2 2023.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Summit X LLC's 13F filing for Q3 2023, filed 6 Nov 2023.